Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new plain-language results summary for the DUO-E trial was added in Publications, with an updated publication date entry (2026-08-07) and revision tag v3.6.5, while older entries from 2026-05 and 2026-06 were removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA page revision update from v3.6.3 to v3.6.4 indicates a maintenance-level change to the page's versioning, with the underlying study information remaining the same.SummaryDifference0.0%

- Check51 days agoChange DetectedThe revision tag was updated from v3.6.2 to v3.6.3. This appears to be a small deployment/build update and does not indicate changes to the page content or data presented.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a newer release or update to the document.SummaryDifference0.0%

- Check72 days agoChange DetectedNew help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label formatting was updated (Intervention/Treatment added, Intervention / Treatment removed), and the page revision updated to v3.6.0.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now reports 201 locations for the study, down from 202, following the removal of Erlangen, Germany. This change updates the live listing to reflect the current sites where the study is conducted.SummaryDifference0.1%

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.